<code id='33636B6BC5'></code><style id='33636B6BC5'></style>
    • <acronym id='33636B6BC5'></acronym>
      <center id='33636B6BC5'><center id='33636B6BC5'><tfoot id='33636B6BC5'></tfoot></center><abbr id='33636B6BC5'><dir id='33636B6BC5'><tfoot id='33636B6BC5'></tfoot><noframes id='33636B6BC5'>

    • <optgroup id='33636B6BC5'><strike id='33636B6BC5'><sup id='33636B6BC5'></sup></strike><code id='33636B6BC5'></code></optgroup>
        1. <b id='33636B6BC5'><label id='33636B6BC5'><select id='33636B6BC5'><dt id='33636B6BC5'><span id='33636B6BC5'></span></dt></select></label></b><u id='33636B6BC5'></u>
          <i id='33636B6BC5'><strike id='33636B6BC5'><tt id='33636B6BC5'><pre id='33636B6BC5'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:98
          om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry
          Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

          CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

          Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

          advertisement

          A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Abridge raises $150m as clinical notes automation market heats up
          Abridge raises $150m as clinical notes automation market heats up

          AdobeAPittsburghartificialintelligencestartupemergingasachallengertoMicrosoft’sclinicalnotetakingbus

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          In 'major milestone,' FDA approves first cell therapy for solid tumors

          MetastaticmelanomacellsJulioC.Valencia,/NCICenterforCancerResearchNearlyfourdecadesafteritsfirstconc